UALCAN analysis revealed that low CDCA7 expression was correlated with low tumor grade, while the expression of CDCA7 progressively increased from stage 2 to stage 3 in ovarian cancer samples (Supplementary Figure S4B). This evidence concerns the gene CDCA7 and neoplasm.